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maps besot' on actual underlying anatomy. Additionally, this npprocch aided 
substnntlntly tn conceptualizing target atltnl structures, With additional devel- 
opment, an on.line tool for use In guiding ablation el cardiac tissue is now 
plauslblo, 
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83["~- 1~ Hypertrophic Cardlomyopathy In the "real World": 
Pritvalsncs, Demographics and Clinical Expression 
In an Unuls©ted and Unroferrad Hospital,baaed 
Patient Population 
B,J, M~ron, L,L', Pellet, S,A, Casoy, Mmnenpohs He,trf In,~fil¢~tn 
Foundation, Ml~meapnlls, MN, USA 
B~ckgro~tnd; Hypertrophic oardiomyopathy (HCM) is the mo~t (~ommon cause 
ol suddoo d~ath in tl~n young, including oompstllivo alhlolea. Establishing 
the pmv~lonc(~ and clinical profiles ol HCM In variet~ populatinns ~s ¢lructial 
tO achieving n Ima perception ol its clinical ~mpnol, Ptevalonoo el HCM in 
g~noral (non-l~o,spit¢~t-ba~nd) populalioh Itns been ptevio~sty repoded as 
O, 17%, 
Molhod,q: In this study, we assessed oc~nurmncn and oilnical 1natures ot 
HCM in an ~4n~olocted pt ,~ohert not subloct to tortialy senior role~ral bt~s, 
R~.'~=~lt.~: Between tg50 and 1995, 131,545 cardiac pts wore ovnlualod: 
P,~I (0,17%', 1,711,000) proved to hnvo HCM Age at diagno,~is was 4-87 
yoom (moan 50 I 1~); 121 (55%) wore male, Loll ventrieular (LV) wall 
thickness was 15-,,38 mm (moan 22 t 5), Hypertrophy was most commonly 
diffuse, In 2 or 3 LV segments 1135 pie; 61%), but was Iocall;~od to only 1 
segment m 80 pt,~ (39%), Outflow obstruction (gradient .30 mm Hg) was 
present tn 51 pt~ (23%), Most pls 1129 or 58%) bad no or only m~ld symptoms; 
g2 (42%) had moderate.severe symptoms, 
Conctu.'~nn.'~, In an un,'~etncled hospital-based pt population evaluated for 
hear dlseast:, the prevalence of HCM was 1:500 10.17%) identical 10 tls 
occurrence in the general populabon. In a "foal,world" clinical setting, most 
HCM pts have little o~' no symptoms, unlike tertiary centers in whicl~ most pts 
are severely symptomntm 
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~835, -~  Long.term Outcome of Hypertrophic 
Csrd lomyopathy  With MId-Ventr loular  Obst ruct ion  
A Woo, ED Wiglo, RC Rakowski, S C Siu, H. Rakowski. The Toronto 
,'-Io,~pitaL Toronto, Canada 
B~lckground: Hypertrophic cardicmvopathy (HCM) with midvontncular form 
of HCM whose long.term oufoomes are unknown, 
Method.~: Forty-one pls witl~ HCM and MVO underwent serial clinical and 
echo-Doppler assessments. There were 19 men (44%), Moan ago was 37.3 
years (range, 11-67 years), The moan loUow-up was 8 years (range, 1-27 
years). 
Results: Presenting features wore oh, sprigs (83%), angina (70%), syncope 
116%), and a long d=astohc murmur 151%), The latter was associated with 
a diastolic mid-cavity gradient. A lamily history el HCM was present in 
44% with non-MVO terms ot HCM predominating, The moan MVO gradient 
was 50 (range, 25-112) mmHg. Associated LV outtlow tract obstruction 
(LVOTO) was present in 15 pts (37%) with a moan gradient of 59 mmHg. 
Follow-up: Atrial fibrillation was uncommon 112%) with no thremboembolic 
events. Sustained vontricular tachycardin (VT) occurred in 2 patients (5%) 
and only in association with an apical infamtion, Dual chamber (DDD) pacing 
tar MVO resulted in moan gradient reduction of 52 to 32 mmHg in 3/4 pts 
(75%). Surgical myoctomy decreased mean MVO gradient (40 to 10 mmHg) 
in 6/9 pts but increased mean MVO gradient (29 to 56 mmHg) in 3 pts 
when LVOTO alone was relieved. There were 3 cardiac deaths, ', tallowing 
myectomy and 2 related to apical infarction and VT. 
Conclusions: HCM with MVO has a relatively benign prognosis in the 
absence of apical infarction. Treatment with DDD pacing or myecfomy is only 
of variable benefit. 
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~'~ Acute Results of Catheter Treatment In Hypertrophic 
Obstructive Cardlomyopsthy 
H. Seggewlss, L, Fabor, U Gleichmttnn, D, Fassbondor, S, Strick, Dept of 
Cardiology, Heclrt Center NRW, Rultr.Unlvetsit), Bochum, Btld Ooynhausen, 
Gnrm,lny 
Backgre=md: Parcutanoous transtuminal septal myocardial ablation (PTSMA) 
seems to be n promi~ing treatment option in symptomatio pt~, with HOCM 
We report on the saute m~ulls in 83 pt~, 
Motherly: 83 symptomsti¢~ pie, (41 man; ago 54,2 t 14,4 yearn; 5 pts, with 
prior myoctomy; 6 ptt~, with L)DD.pa,~at; 32 pt~, with prior sync~ope; NYHA 
class 2,7 :i: 0,6) worn treated, LVOT grcldionts (LVQTG) were simultaneously 
me,~urod at met and post o~trasystala (ES). 1 1 :t- 0,411-3) soptat branches 
worn oocluded by Ininctlon of 35 t 1,6 ml abooh.de ntoohol during balloon 
dilatation el the proximal prtrt of the soptal branch with an over the wire 
balloon cath0ter 
Reset/re: LVOTG mduc~tioo was achieved in 77 (94%) pts.; complete in 
;~1 (~5%), -50%, in 49 159%), and 20-.49% in 8 110%) pts. LVQTG worn 
reduced trnm 74,4 t 35.t to t73  * ?nO mmHg at met iP ~ 0.00001) 
end Item 147,3 r 423 to 623 t 455 mmHg post ES (p < 000001) Pts 
with solve gtitdod identification o! the target septal branch (n = ~)  hod n 
higb0r LVOTG reduotion (79 t 24% vs, 6-1 :t 38'%; p = 0.04). 54 (65%) pts 
developed tntoscicular block, mqumng tomporan/(n = 43) or permanent (n 
= 11; 13%) pacemak0r. 43 (52%) pie. had now .predominantly nght - bundle 
branch blocks Maximal CK nso was 66;' t 331 U/I. 2 (24%) pfs died from 
vontnculnr libnllation (day 9) o¢ pulmonary embolism (day 2). 
Conclusion: PTS'~,~A el HOCM is a promising treatment options in symp- 
tomatlc pts, Careful momtnnng du,ng hospital stay =s neeassaq/ because 
of the potential nsks at the therapeutic infamtion. Long-term follow.up and 
comparison with conventional treatment is necessary in order to e~timate its 
definitive therapeutic signtlicanco. 
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~ Porcutaneous Translumlnal Septet Myocardial 
Ablation In Hyper t roph ic  Obst ruct ive  
Cardlomyopathy: Cllnl©al and Non-lnvaslve 
Fo l low-up  Resul ts  
H Seggowiss, L. Faber, U. Gleichmann, S. Stnck, P. Ziemssen. Dept at 
Cardlolog)~ Heart Center NRVV Ruhr*Una,ersit],o B churn. Bad Oeynhausen. 
Germany 
Background" Pemutanoous Iranslummal septet myocardial ablation (PTSMA) 
by alcohol reduced septet branch occlusion in pts. with HOCM results in acute 
reduction el left ventricular outflow tract gradients (LVOTG) in 90% el the pts 
Mid- and long-term follow-up results are unknown. 
Methods. 49/53 symptomahc pts. (26 men: age 513 : 150 years; 3 
pts. with prior myectomy, 21 pts. with pnor syncope: NYHA class 2.7 ~ 0 6) 
showed significant reduction ot LVOTG alter PTSMA. Mean LVOTG ,,,.*ere 
reduced tram 58.9 "~: 43.3 to 285:1:26.6 mmHg at rest and tram 142 7 .~ 
53.9 to 70.7 ~ 53.3 mmHg at stress (each p.  0.00001 ). 7113%) pfs. required 
DDD-pacemaker (PM) due to permanent tnlasc~cular block. We report on 3 
months follow-up in 53 pts. and 1 year follow-up in 12 pts. alter PTSMA 
Results: No cardiac complications wore obsewed dunng follow-up. After 
3 months 49 (92.5%) pts showed clinical impovemont (NYHA t.2 ~ 1.0: p < 
0.00001 ) with an increase of workload from 90.7 ~- 62.0 to 114.0 :t: 41.4 Watts 
(p • 0.01) - the results were compc4rablo in pts. with and without DDD-PM 4 
pts. undoP, vent successful re-PTSMA. 29 (55%) pts. showed further LVOTG 
reduction. Compared to acute results mean LVOTG decreased to 19.2 
18.2 mmHg at rest (p - 0.001) and to 58.7 ± 47.6 mmHg at stress (p = 0.03). 
Furthermore, we observed sigmltcant reduction of septa1121.5 ~,. 37 to 17.7 
: 3.4 ram; p ,  0.0001) and left posterior wall thickness (142 ~: 2.5 to 132 
t 2.1 mm; p ,: 0.001) as well as decrease of pulmonary artery pressure at 
max. workload (43.4 t 11.9 vs. 39.9 ~- 10.1 mmHg; p = 0.04). Alter 1 year 
5/12 (42%) pts. showed further LVOTG reduction and ongoing symptomatic 
improvement (NYHA t 2 ,, 1.2). 
Conclusion: After PTSMA pts. showed ongoing symptomatic improve- 
ment. Remodeling after circumscnbod septal infarction results in turther 
LVOTG reduction in -50%, of the pls. 
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~-~ Acute and Long- term Resu l ts  A f te r  T ranscoronary  
Ablation of Septum Hypertrophy in Hypertrol~hic 
Card iomyopathy  
FH. Gietzen, H.J. Kuhn, C.J. Leuner, J. Hogsolmann, C. Strunk-Mueller. 
Dept. of Cardiology, Bielefeld Hospital. Bielefeld, Germany 
We report on 67 transcoronary ablations of septum hypertrophy (TASH) in 
